Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In return for the license, Ascendis will be eligible to receive total payments of up to $285 million in upfront, development, and regulatory milestone payments for the lead program
Internal documents emerging through litigation discovery suggest the company failed to implement stronger safety warnings about gastrointestinal risks despite being well aware of the off-label prescribing trends and choosing to prioritize market expansion
doi:10.2307/1564290
When your appetite drops dramatically, it can become challenging to consume enough protein
US$ 27.85
US$ 21.28
US$ 27.96
